Work

Trabectedin (T)-related liver toxicity: Results of a pharmacokinetic study with T in patients with hepatic dysfunction (OVC1004) and experience from a phase 3 clinical trial (SAR3007).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.11064

Authors: Emiliano Calvo, Analia Azaro, Luc Dirix, Manon Huizing, Francis Mark Senecal, Patricia LoRusso, Lorrin Yee, Chi Fung Keung, Spyros Triantos, Youn C. Park, Roland Elmar Knoblauch, Trilok V. Parekh, George D. Demetri, Margaret vonMehren

Institutions: Vall d'Hebron Institute of Oncology, GZA Ziekenhuizen Campus Sint-Augustinus, GZA Ziekenhuizen, Antwerp University Hospital, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Northwest Medical Specialties, Janssen Research & Development (United States), Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Fox Chase Cancer Center

Language: English

Topic: Drug-Induced Hepatotoxicity and Protection

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891454145

Cites:

Cited by: 2

Related to: 10